Lemzoparlimab [2377483-71-9]
Référence T78246-1mg
Conditionnement : 1mg
Marque : TargetMol
Contactez votre distributeur local :
Téléphone : +1 850 650 7790
Lemzoparlimab
(Synonyms: TJC4, TJC 4, TJ011133, TJ 011133) Copy Product InfoLemzoparlimab (TJ011133) is a differentiated anti-CD47 humanized antibody with anti-tumor activity, used in the study of myeloid leukemia.
Cas No. 2377483-71-9
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
For research use only—not for human use. No sales to individuals. Use as intended only.
Select Batch
Purity:98.44% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
COA SEC-HPLC SDS-PAGE ELISA Instruction Manual of Inhibitory Antibody
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Lemzoparlimab (TJ011133) is a differentiated anti-CD47 humanized antibody with anti-tumor activity, used in the study of myeloid leukemia. |
| Synonyms | TJC4, TJC 4, TJ011133, TJ 011133 |
| Reactivity | Human |
| Verified Activity | Immobilized Human CD47 Protein (His) (TMPJ-00211) at 1 μg/mL (100 μL/well) can bind Lemzoparlimab. The EC50 is 157 ng/mL.  |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | 961 |
| Uniprot ID | Q08722 |
| Target | CD47 |
| Molecular Weight | 145.58 kDa |
| Cas No. | 2377483-71-9 |
| Isotype | Human IgG4SP kappa |
| Recommended Isotype Control | Human IgG4 (S228P) kappa, Isotype Control |
| Storage | Store at low temperature -20°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |